Eriksson J E, Hanson A, Hörlin R, Johansson B W, Ohlsson O, Otto U, Syrén G
Acta Med Scand. 1979;205(1-2):53-9. doi: 10.1111/j.0954-6820.1979.tb06003.x.
A new sustained release preparation (Lipettes) of quinidine has been evaluated with regard to dissolution, absorption, serum concentration and side-effects. The serum levels of quinidine after single oral doses and after long-term treatment have been compared with the serum levels after administration of some other quinidine preparations on the Swedish market. The side-effects of the sustained release preparations have also been studied. Results indicated that this new sustained release quinidine preparation yields more even serum concentrations of quinidine and seemed to cause less troublesome side-effects than the marketed preparations.
已对一种新的奎尼丁缓释制剂(Lipettes)的溶出度、吸收情况、血清浓度及副作用进行了评估。将单次口服剂量及长期治疗后奎尼丁的血清水平与瑞典市场上其他一些奎尼丁制剂给药后的血清水平进行了比较。还研究了缓释制剂的副作用。结果表明,这种新的奎尼丁缓释制剂能使奎尼丁的血清浓度更均匀,且与市售制剂相比,似乎引起的副作用更少。